Temat: "COVID-19 Vaccines"

Skocz do pozycji: 1 1.

Tytuł :: Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors.
Autorzy :: Waldhorn I; Division of Oncology, Rambam Health Care Campus, Haifa, Israel.
Holland R; Division of Oncology, Rambam Health Care Campus, Haifa, Israel.
Goshen-Lago T; Division of Oncology, Rambam Health Care Campus, Haifa, Israel.
Shirman Y; Division of Oncology, Rambam Health Care Campus, Haifa, Israel.
Szwarcwort-Cohen M; Virology Laboratory, Rambam Health Care Campus, Haifa, Israel.
Reiner-Benaim A; Clinical Epidemiology Unit, Rambam Health Care Campus, Haifa, Israel.
Shachor-Meyouhas Y; General Management, Rambam Health Care Campus, Haifa, Israel.; Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Hussein K; General Management, Rambam Health Care Campus, Haifa, Israel.; Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Fahoum L; Division of Oncology, Rambam Health Care Campus, Haifa, Israel.
Peer A; Division of Oncology, Rambam Health Care Campus, Haifa, Israel.
Almog R; Clinical Epidemiology Unit, Rambam Health Care Campus, Haifa, Israel.
Shaked Y; Rappaport Faculty of Medicine, Technion, Haifa, Israel.; Technion-Integrated Cancer Center, Technion, Haifa, Israel.
Halberthal M; General Management, Rambam Health Care Campus, Haifa, Israel.; Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Ben-Aharon I; Division of Oncology, Rambam Health Care Campus, Haifa, Israel. .; Rappaport Faculty of Medicine, Technion, Haifa, Israel.; Technion-Integrated Cancer Center, Technion, Haifa, Israel.; Pokaż więcej
Źródło :: Cancer discovery [Cancer Discov] 2021 Oct; Vol. 11 (10), pp. 2430-2435. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Neoplasms*/drug therapy
COVID-19 Vaccines/*adverse effects
COVID-19 Vaccines/*pharmacology
Adult ; Aged ; Aged, 80 and over ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/immunology ; Health Personnel ; Humans ; Male ; Middle Aged ; Neutropenia/chemically induced ; Thrombocytopenia/chemically induced ; Time-to-Treatment ; Vaccination
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Myocarditis With COVID-19 mRNA Vaccines.
Autorzy :: Bozkurt B; Winters Center for Heart Failure Research, Cardiovascular Research Institute (B.B.), Baylor College of Medicine, DeBakey VA Medical Center, Houston, TX.
Kamat I; Department of Medicine (I.K.), Baylor College of Medicine, DeBakey VA Medical Center, Houston, TX.
Hotez PJ; Department of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine (P.J.H.), Baylor College of Medicine, DeBakey VA Medical Center, Houston, TX.; Pokaż więcej
Źródło :: Circulation [Circulation] 2021 Aug 10; Vol. 144 (6), pp. 471-484. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Autoantigens/*immunology
COVID-19/*prevention & control
COVID-19 Vaccines/*adverse effects
Myocarditis/*chemically induced
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Biomarkers ; COVID-19/epidemiology ; COVID-19/immunology ; COVID-19 Vaccines/immunology ; COVID-19 Vaccines/therapeutic use ; Female ; Humans ; Male ; Molecular Mimicry/immunology ; Myocarditis/immunology ; Sex Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society.
Autorzy :: Ku CR; Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Jung KY; Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University, Seoul, Korea.
Ahn CH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Moon JS; Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea.
Lee JH; Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University College of Medicine, Daejeon, Korea.
Kim EH; Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine and Biomedical Research Institute, Busan, Korea.
Kwon H; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim HK; Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
Suh S; Department of Internal Medicine, Dong-A University Medical Center, Dong-A University College of Medicine, Busan, Korea.
Hong S; Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
Ha J; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Roh E; Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Kim JH; Department of Internal Medicine, Chosun University Hospital, Chosun University College of Medicine, Gwangju, Korea.
Kim MK; Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.; Pokaż więcej
Corporate Authors :: Committee of Clinical Practice Guideline of the Korean Endocrine Society
Źródło :: Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2021 Aug; Vol. 36 (4), pp. 757-765. Date of Electronic Publication: 2021 Aug 17.
Typ publikacji :: Journal Article
MeSH Terms :: Endocrine System Diseases*/epidemiology
Endocrine System Diseases*/immunology
COVID-19/*prevention & control
COVID-19 Vaccines/*standards
Endocrinologists/*standards
Societies, Medical/*standards
Vaccination/*standards
COVID-19/epidemiology ; COVID-19/immunology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/adverse effects ; Humans ; Practice Guidelines as Topic/standards ; Republic of Korea/epidemiology
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 4 4.

Tytuł :: Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infection.
Autorzy :: Meyer M; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Galveston National Laboratory, Galveston, Texas, USA.
Wang Y; Department of Computer Science and.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, New Jersey, USA.
Edwards D; Moderna Inc., Cambridge, Massachusetts, USA.
Smith GR; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Rubenstein AB; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ramanathan P; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Galveston National Laboratory, Galveston, Texas, USA.
Mire CE; Galveston National Laboratory, Galveston, Texas, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Pietzsch C; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Galveston National Laboratory, Galveston, Texas, USA.
Chen X; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, New Jersey, USA.; Center for Computational Biology, Flatiron Institute, Simons Foundation, New York, New York, USA.
Ge Y; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Cheng WS; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Henry C; Moderna Inc., Cambridge, Massachusetts, USA.
Woods A; Moderna Inc., Cambridge, Massachusetts, USA.
Ma L; Moderna Inc., Cambridge, Massachusetts, USA.
Stewart-Jones GB; Moderna Inc., Cambridge, Massachusetts, USA.
Bock KW; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Minai M; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Nagata BM; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Periasamy S; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Galveston National Laboratory, Galveston, Texas, USA.
Shi PY; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA.
Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Moore IN; Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Ramos I; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Troyanskaya OG; Department of Computer Science and.; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, New Jersey, USA.; Center for Computational Biology, Flatiron Institute, Simons Foundation, New York, New York, USA.
Zaslavsky E; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Carfi A; Moderna Inc., Cambridge, Massachusetts, USA.
Sealfon SC; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Bukreyev A; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.; Galveston National Laboratory, Galveston, Texas, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA.; Pokaż więcej
Źródło :: The Journal of clinical investigation [J Clin Invest] 2021 Oct 15; Vol. 131 (20).
Typ publikacji :: Journal Article
MeSH Terms :: SARS-CoV-2*/immunology
SARS-CoV-2*/physiology
COVID-19/*immunology
COVID-19/*prevention & control
COVID-19 Vaccines/*pharmacology
Lung/*immunology
Animals ; Antibodies, Neutralizing/biosynthesis ; Antibodies, Viral/biosynthesis ; COVID-19/virology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/immunology ; Disease Models, Animal ; Female ; Humans ; Immunization, Secondary ; Lung/pathology ; Lung/virology ; Lymphocyte Activation ; Mesocricetus ; Single-Cell Analysis ; Virus Replication
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Considerations in boosting COVID-19 vaccine immune responses.
Autorzy :: Krause PR; Office of Vaccines Research and Review, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: .
Fleming TR; Department of Biostatistics, University of Washington, Seattle, WA, USA.
Peto R; Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Longini IM; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
Figueroa JP; University of the West Indies, Mona, Jamaica.
Sterne JAC; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Cravioto A; Universidad Nacional Autónoma de México, DF, Mexico.
Rees H; Wits Reproductive Health and HIV Institute, Johannesburg, South Africa.
Higgins JPT; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Boutron I; Centre of Research in Epidemiology and Statistics (CRESS), Université de Paris, Paris, France.
Pan H; MRC Population Health Research Unit, University of Oxford, Oxford, UK.
Gruber MF; Office of Vaccines Research and Review, Food and Drug Administration, Silver Spring, MD, USA.
Arora N; The INCLEN Trust International, New Delhi, India.
Kazi F; World Health Organization, Geneva, Switzerland.
Gaspar R; World Health Organization, Geneva, Switzerland.
Swaminathan S; World Health Organization, Geneva, Switzerland.
Ryan MJ; World Health Organization, Geneva, Switzerland.
Henao-Restrepo AM; World Health Organization, Geneva, Switzerland. Electronic address: .; Pokaż więcej
Źródło :: Lancet (London, England) [Lancet] 2021 Oct 09; Vol. 398 (10308), pp. 1377-1380. Date of Electronic Publication: 2021 Sep 14.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: COVID-19/*prevention & control
COVID-19 Vaccines/*administration & dosage
Evidence-Based Medicine/*standards
Immunization, Secondary/*standards
SARS-CoV-2/*pathogenicity
COVID-19/epidemiology ; COVID-19/immunology ; COVID-19/virology ; COVID-19 Vaccines/adverse effects ; COVID-19 Vaccines/immunology ; Evidence-Based Medicine/methods ; Evidence-Based Medicine/statistics & numerical data ; Humans ; Immunity ; Immunization, Secondary/methods ; Immunization, Secondary/statistics & numerical data ; Immunogenicity, Vaccine ; Observational Studies as Topic ; Pandemics/prevention & control ; Randomized Controlled Trials as Topic ; SARS-CoV-2/immunology ; Treatment Outcome
SCR Organism :: SARS-CoV-2 variants
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Inequalities in coverage of COVID-19 vaccination: A population register based cross-sectional study in Wales, UK.
Autorzy :: Perry M; Vaccine Preventable Disease Programme and Communicable Disease Surveillance Centre, Public Health Wales, 2 Capital Quarter, Tyndall Street, Cardiff CF10 4BZ, Wales, UK; Population Data Science, Health Data Research UK, Swansea University Medical School, Swansea SA2 8PP, Wales, UK. Electronic address: .
Akbari A; Population Data Science, Health Data Research UK, Swansea University Medical School, Swansea SA2 8PP, Wales, UK. Electronic address: .
Cottrell S; Vaccine Preventable Disease Programme and Communicable Disease Surveillance Centre, Public Health Wales, 2 Capital Quarter, Tyndall Street, Cardiff CF10 4BZ, Wales, UK. Electronic address: .
Gravenor MB; Population Data Science, Health Data Research UK, Swansea University Medical School, Swansea SA2 8PP, Wales, UK. Electronic address: .
Roberts R; Vaccine Preventable Disease Programme and Communicable Disease Surveillance Centre, Public Health Wales, 2 Capital Quarter, Tyndall Street, Cardiff CF10 4BZ, Wales, UK. Electronic address: .
Lyons RA; Population Data Science, Health Data Research UK, Swansea University Medical School, Swansea SA2 8PP, Wales, UK. Electronic address: .
Bedston S; Population Data Science, Health Data Research UK, Swansea University Medical School, Swansea SA2 8PP, Wales, UK. Electronic address: .
Torabi F; Population Data Science, Health Data Research UK, Swansea University Medical School, Swansea SA2 8PP, Wales, UK. Electronic address: .
Griffiths L; Population Data Science, Health Data Research UK, Swansea University Medical School, Swansea SA2 8PP, Wales, UK. Electronic address: .; Pokaż więcej
Źródło :: Vaccine [Vaccine] 2021 Oct 08; Vol. 39 (42), pp. 6256-6261. Date of Electronic Publication: 2021 Sep 08.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: COVID-19*
COVID-19 Vaccines*
Aged ; Cross-Sectional Studies ; Ethnic Groups ; Humans ; Male ; Middle Aged ; Minority Groups ; Pandemics ; Registries ; SARS-CoV-2 ; United Kingdom ; Vaccination ; Wales/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: The relationship of Covid-19 vaccine attitude with life satisfaction, religious attitude and Covid-19 avoidance in Turkey.
Autorzy :: Kilic M; Faculty of Medicine Department of Public Health, Yozgat Bozok University, Yozgat, Turkey.
Ustundag Ocal N; Vocational School of Health, Yozgat Bozok University, Yozgat, Turkey.
Uslukilic G; Health Practice and Research Center Hospital, Yozgat Bozok University, Yozgat, Turkey.; Pokaż więcej
Źródło :: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Oct 03; Vol. 17 (10), pp. 3384-3393. Date of Electronic Publication: 2021 Jul 26.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*
COVID-19 Vaccines*
Adolescent ; Adult ; Attitude ; Cross-Sectional Studies ; Humans ; Male ; Personal Satisfaction ; SARS-CoV-2 ; Turkey
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: A rational strategy to support approved COVID-19 vaccines prioritization.
Autorzy :: Burgos-Salcedo J; Biomathematics Department, Corporación para la Investigación y la Innovación-CIINAS, Colombia.; Centro de investigaciones, Fundación Universitaria San Mateo, Colombia.; Pokaż więcej
Źródło :: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Oct 03; Vol. 17 (10), pp. 3474-3477. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*
COVID-19 Vaccines*
Humans ; SARS-CoV-2 ; World Health Organization
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: [The impact of immunosuppression and chronic kidney disease on immunogenicity of COVID-19 vaccines].
Autorzy :: Windpessl M; Innere Medizin IV, Klinikum Wels-Grieskirchen, Wels, Österreich.; Medizinische Fakultät, Kepler-Universitätsklinikum, Linz, Österreich.
Heine GH; Medizinische Klinik II, AGAPLESION MARKUS-KRANKENHAUS, Frankfurt, Deutschland.; Universität des Saarlandes, Homburg, Deutschland.
Becker SL; Institut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum des Saarlandes, Homburg, Deutschland.
Scheuer AL; Medizinische Klinik II, AGAPLESION MARKUS-KRANKENHAUS, Frankfurt, Deutschland.; Universität des Saarlandes, Homburg, Deutschland.
Sester M; Abteilung für Transplantations- und Infektionsimmunologie, Universitätsklinikum des Saarlandes, Homburg, Deutschland.
Kronbichler A; Department of Medicine, University of Cambridge, United Kingdom.; Pokaż więcej
Transliterated Title :: Der Einfluss von Immunsuppression und chronischen Nierenerkrankungen auf das Ansprechen auf COVID-19-Impfungen.
Źródło :: Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 2021 Oct; Vol. 146 (19), pp. 1277-1282. Date of Electronic Publication: 2021 Sep 22.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19 Vaccines*/administration & dosage
COVID-19 Vaccines*/immunology
Immunosuppressive Agents*/adverse effects
Immunosuppressive Agents*/therapeutic use
Renal Insufficiency, Chronic/*therapy
Antibodies, Viral/blood ; Antibodies, Viral/immunology ; COVID-19/prevention & control ; Humans ; Immunosuppression
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine.
Autorzy :: Lavery MJ; Department of Dermatology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.; Department of Dermatology, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, UK.
Nawimana S; Department of Dermatology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Parslew R; Department of Dermatology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.; Department of Dermatology, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, UK.
Stewart L; Department of Dermatology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.; Pokaż więcej
Źródło :: Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Oct; Vol. 46 (7), pp. 1325-1327. Date of Electronic Publication: 2021 May 25.
Typ publikacji :: Case Reports; Letter
MeSH Terms :: COVID-19/*prevention & control
COVID-19 Vaccines/*adverse effects
Erythema Multiforme/*chemically induced
Administration, Topical ; COVID-19/diagnosis ; COVID-19/immunology ; COVID-19/virology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/therapeutic use ; Clobetasol/administration & dosage ; Clobetasol/therapeutic use ; Erythema Multiforme/drug therapy ; Erythema Multiforme/pathology ; Female ; Glucocorticoids/administration & dosage ; Glucocorticoids/therapeutic use ; Humans ; Middle Aged ; Preexisting Condition Coverage ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology ; Symptom Flare Up ; Treatment Outcome
: Raport

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: COVID-19 vaccine willingness amongst patients with mental illness compared with the general population.
Autorzy :: Jefsen OH; Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Kølbæk P; Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Gil Y; Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Speed M; Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.
Dinesen PT; Department of Political Science, University of Copenhagen, Copenhagen, Denmark.
Sønderskov KM; Department of Political Science, Aarhus University, Aarhus, Denmark.
Østergaard SD; Department of Affective Disorders, Aarhus University Hospital - Psychiatry, Aarhus, Denmark.; Pokaż więcej
Źródło :: Acta neuropsychiatrica [Acta Neuropsychiatr] 2021 Oct; Vol. 33 (5), pp. 273-276. Date of Electronic Publication: 2021 May 17.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19/*psychology
COVID-19 Vaccines/*therapeutic use
Mental Disorders/*immunology
Patient Acceptance of Health Care/*psychology
Adult ; Aged ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/immunology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/immunology ; COVID-19 Vaccines/supply & distribution ; Case-Control Studies ; Denmark/epidemiology ; Female ; Humans ; Male ; Mental Disorders/mortality ; Mental Disorders/virology ; Middle Aged ; Patient Acceptance of Health Care/statistics & numerical data ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification ; Surveys and Questionnaires
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: COVID-19 vaccine uptake in patients with psychiatric disorders admitted to or residing in a university psychiatric hospital.
Autorzy :: Mazereel V; University Psychiatric Center, KU Leuven, Leuven-Kortenberg 3070, Belgium; Center for Clinical Psychiatry, Department of Biomedical Sciences, KU Leuven, Leuven, Belgium.
Vanbrabant T; University Psychiatric Center, KU Leuven, Leuven-Kortenberg 3070, Belgium.
Desplenter F; University Psychiatric Center, KU Leuven, Leuven-Kortenberg 3070, Belgium; Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; Antwerp Health Law and Ethics Chair, University Antwerpen, Antwerp, Belgium.
De Hert M; University Psychiatric Center, KU Leuven, Leuven-Kortenberg 3070, Belgium; Center for Clinical Psychiatry, Department of Biomedical Sciences, KU Leuven, Leuven, Belgium. Electronic address: .; Pokaż więcej
Źródło :: The lancet. Psychiatry [Lancet Psychiatry] 2021 Oct; Vol. 8 (10), pp. 860-861. Date of Electronic Publication: 2021 Aug 17.
Typ publikacji :: Comparative Study; Letter
MeSH Terms :: COVID-19/*prevention & control
COVID-19 Vaccines/*supply & distribution
Hospitalization/*statistics & numerical data
Mental Disorders/*therapy
Vaccination/*statistics & numerical data
Vulnerable Populations/*statistics & numerical data
Adult ; Aged ; Attitude to Health ; Belgium/epidemiology ; COVID-19/complications ; COVID-19/epidemiology ; COVID-19/psychology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/standards ; Female ; Hospitals, Psychiatric/statistics & numerical data ; Hospitals, University ; Humans ; Male ; Mental Disorders/epidemiology ; Mental Disorders/mortality ; Mental Disorders/psychology ; Middle Aged ; Morbidity/trends ; SARS-CoV-2/genetics ; Severity of Illness Index ; Vulnerable Populations/psychology
: Raport

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT.
Autorzy :: Redjoul R; Haematology Department, Assistance Publique, Hôpitaux de Paris, Henri Mondor Hospital, Créteil 94000, France.
Le Bouter A; Virology Department, Assistance Publique, Hôpitaux de Paris, Henri Mondor Hospital, Créteil 94000, France.
Parinet V; Haematology Department, Assistance Publique, Hôpitaux de Paris, Henri Mondor Hospital, Créteil 94000, France.
Fourati S; Virology Department, Assistance Publique, Hôpitaux de Paris, Henri Mondor Hospital, Créteil 94000, France; INSERM U955, Université Paris Est Créteil Val de Marne, Créteil, France.
Maury S; Haematology Department, Assistance Publique, Hôpitaux de Paris, Henri Mondor Hospital, Créteil 94000, France; INSERM U955, Université Paris Est Créteil Val de Marne, Créteil, France. Electronic address: .; Pokaż więcej
Źródło :: The Lancet. Haematology [Lancet Haematol] 2021 Oct; Vol. 8 (10), pp. e681-e683. Date of Electronic Publication: 2021 Sep 03.
Typ publikacji :: Journal Article
MeSH Terms :: Hematopoietic Stem Cell Transplantation*
COVID-19/*prevention & control
COVID-19 Vaccines/*therapeutic use
Aged ; Antibody Formation ; COVID-19/immunology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/immunology ; Female ; Humans ; Immunity, Humoral ; Male ; Middle Aged ; SARS-CoV-2/immunology ; Transplantation, Homologous
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development.
Autorzy :: Moradi-Kalbolandi S; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, 1517964311, Tehran, Iran.
Majidzadeh-A K; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, 1517964311, Tehran, Iran.
Abdolvahab MH; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, 1517964311, Tehran, Iran.
Jalili N; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, 1517964311, Tehran, Iran.
Farahmand L; Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, 1517964311, Tehran, Iran. .; Pokaż więcej
Źródło :: Probiotics and antimicrobial proteins [Probiotics Antimicrob Proteins] 2021 Oct; Vol. 13 (5), pp. 1239-1253. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Immunity, Mucosal*
COVID-19/*immunology
COVID-19 Vaccines/*immunology
Lactobacillales/*genetics
SARS-CoV-2/*immunology
Animals ; COVID-19/microbiology ; COVID-19/prevention & control ; COVID-19/virology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/genetics ; Drug Development ; Gastrointestinal Microbiome ; Gene Expression ; Humans ; Lactobacillales/immunology ; SARS-CoV-2/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: COVID-19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast.
Autorzy :: Pacifico A; Clinical Dermatology Department, IRCCS S. Gallicano Dermatological Institute, Rome, Italy.
d'Arino A; Clinical Dermatology Department, IRCCS S. Gallicano Dermatological Institute, Rome, Italy.
Pigatto PDM; Clinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Malagoli P; Dermatology Unit, Azienda Ospedaliera San Donato Milanese, Milan, Italy.
Young Dermatologists Italian Network; Study Centre of the Italian Group for Epidemiologic Research in Dermatology (GISED), Bergamo, Italy.
Damiani G; Clinical Dermatology, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.; Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.; Pokaż więcej
Źródło :: Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Oct; Vol. 46 (7), pp. 1344-1346. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :: Case Reports; Letter
MeSH Terms :: COVID-19/*prevention & control
COVID-19 Vaccines/*adverse effects
Psoriasis/*drug therapy
Thalidomide/*analogs & derivatives
Administration, Oral ; Adult ; Aged ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19/virology ; COVID-19 Vaccines/administration & dosage ; COVID-19 Vaccines/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Phosphodiesterase 4 Inhibitors/administration & dosage ; Phosphodiesterase 4 Inhibitors/therapeutic use ; Psoriasis/pathology ; SARS-CoV-2/genetics ; Symptom Flare Up ; Thalidomide/administration & dosage ; Thalidomide/therapeutic use
: Raport

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Anaphylaxis and Coronavirus Disease 2019 vaccine: a danger relationship?
Autorzy :: Tanno LK; Institut Desbrest d'Epidémiologie et de Santé Publique, IDESP UMR UA11 INSERM, University of Montpellier.; WHO Collaborating Center for Classification Scientific Support, University Hospital of Montpellier, Montpellier, France.; Hospital Sirio-Libanês, São Paulo, Brazil.
Castells M; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Caminati M; Department of Medicine, University of Verona.
Senna G; Department of Medicine, University of Verona.; Allergy Unit and Asthma Center, University of Verona and Verona University Hospital, Verona, Italy.
Demoly P; Institut Desbrest d'Epidémiologie et de Santé Publique, IDESP UMR UA11 INSERM, University of Montpellier.; WHO Collaborating Center for Classification Scientific Support, University Hospital of Montpellier, Montpellier, France.; Pokaż więcej
Źródło :: Current opinion in allergy and clinical immunology [Curr Opin Allergy Clin Immunol] 2021 Oct 01; Vol. 21 (5), pp. 411-417.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :: Anaphylaxis/*immunology
COVID-19 Vaccines/*adverse effects
Adverse Drug Reaction Reporting Systems ; Anaphylaxis/epidemiology ; Animals ; COVID-19 Vaccines/chemistry ; COVID-19 Vaccines/immunology ; Female ; Humans ; Hypersensitivity/immunology ; Male ; Polyethylene Glycols/adverse effects ; Sex Characteristics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Association of COVID-19 vaccination prioritization and hospitalization among older Washingtonians.
Autorzy :: Lavista Ferres JM; AI for Health, Microsoft Corporation, Redmond, Washington, USA.
Richardson BA; Department of Biostatistics, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.
Weeks WB; Precision Population Health, Microsoft Corporation, Redmond, Washington, USA.; Pokaż więcej
Źródło :: Journal of the American Geriatrics Society [J Am Geriatr Soc] 2021 Oct; Vol. 69 (10), pp. 2780-2782. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :: Letter
MeSH Terms :: COVID-19*/epidemiology
COVID-19*/prevention & control
COVID-19*/therapy
COVID-19 Vaccines*/classification
COVID-19 Vaccines*/therapeutic use
Hospitalization*/economics
Hospitalization*/statistics & numerical data
Vaccination*/methods
Vaccination*/statistics & numerical data
Health Priorities/*organization & administration
Aged ; Efficiency, Organizational ; Female ; Humans ; Immunization Programs/methods ; Immunization Programs/organization & administration ; Male ; SARS-CoV-2 ; Washington/epidemiology
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: SARS-CoV-2 Vaccines: Where Are We Now?
Autorzy :: Flanagan KL; Tasmanian Vaccine Trial Centre, Clifford Craig Foundation, Launceston General Hospital, Launceston, Tas, Australia; School of Medicine, University of Tasmania, Launceston, Tas, Australia; School of Health and Biomedical Science, RMIT University, Bundoora, Vic, Australia; Department of Immunology and Pathology, Monash University, Melbourne, Vic, Australia. Electronic address: .
MacIntyre CR; Biosecurity Research Program, Kirby Institute, UNSW Medicine, University of New South Wales, Sydney, NSW, Australia.
McIntyre PB; Women's and Children's Health, University of Otago, Dunedin, New Zealand.
Nelson MR; Division of Asthma, Allergy and Immunology, University of Virginia, Charlottesville, Va.; Pokaż więcej
Źródło :: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2021 Oct; Vol. 9 (10), pp. 3535-3543. Date of Electronic Publication: 2021 Aug 13.
Typ publikacji :: Journal Article
MeSH Terms :: COVID-19*
COVID-19 Vaccines*
Humans ; Pandemics/prevention & control ; SARS-CoV-2 ; Vaccination
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: COVID-19 challenges and its therapeutics.
Autorzy :: Rehman SU; Department of Pharmacy, Abasyn University Peshawar, Pakistan.
Rehman SU; Department of Pharmacy, Abasyn University Peshawar, Pakistan. Electronic address: .
Yoo HH; Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Republic of Korea. Electronic address: .; Pokaż więcej
Źródło :: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Oct; Vol. 142, pp. 112015. Date of Electronic Publication: 2021 Aug 05.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Antiviral Agents*/classification
Antiviral Agents*/pharmacology
COVID-19 Vaccines*/classification
COVID-19 Vaccines*/pharmacology
COVID-19/*drug therapy
SARS-CoV-2/*drug effects
COVID-19/classification ; COVID-19/complications ; COVID-19/prevention & control ; Drug Development/methods ; Drug Discovery/methods ; Drug Repositioning/methods ; Humans
SCR Protocol :: COVID-19 drug treatment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2.
Autorzy :: Granados-Riveron JT; Laboratorio de Investigación en Patogénesis Molecular, Hospital Infantil de México, Federico Gómez, Ciudad de México, Mexico.
Aquino-Jarquin G; Laboratorio de Investigación en Genómica, Genética y Bioinformática, Hospital Infantil de México, Federico Gómez, Ciudad de México, Mexico. Electronic address: .; Pokaż więcej
Źródło :: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Oct; Vol. 142, pp. 111953. Date of Electronic Publication: 2021 Jul 23.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Biomedical Engineering*/methods
Biomedical Engineering*/trends
COVID-19*/prevention & control
COVID-19*/virology
COVID-19 Vaccines*/classification
COVID-19 Vaccines*/pharmacology
SARS-CoV-2*/drug effects
SARS-CoV-2*/immunology
Drug Development/*methods
Drug Discovery/*methods
Drug Delivery Systems/methods ; Humans ; Immunogenicity, Vaccine ; Liposomes/pharmacology ; Nanoparticles ; Nucleosides/pharmacology ; Nucleosides/physiology ; Spike Glycoprotein, Coronavirus/immunology ; Vaccines, Synthetic/pharmacology
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaBiblioteka WSB w Toruniu

Wyszukujesz frazę ""COVID-19 Vaccines"" wg kryterium: Temat

Źródło danych

Dostawca treści

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Hasło geograficzne

Kolekcja